Opioid victims are not getting a "fair shake" in potential $7.4 billion settlement, a claimant in the Purdue Pharmacy ...

Here's why people alleging Purdue Pharma's opioids harmed them may not see much of the proposed $7.4 billion settlement in a bankruptcy case.

NEW YORK, Feb 25 (Reuters) - Purdue Pharma told a U.S. bankruptcy ... to $750 million set aside for personal injury claims in Purdue’s previous bankruptcy plan. Lane said Tuesday that he was ...

A judge in the US has approved the sale of Purdue Pharma’s ... part of the bankruptcy proceedings related to the drugmaker’s proposed $10 billion settlement of claims that it helped to fuel ...

Judge Littlefield is deciding whether to permit several child sexual abuse lawsuits against the Roman Catholic Diocese of Albany to go to trial as a method to kick start settlement discussions.

Members of the family who own OxyContin maker Purdue Pharma ... Purdue sought bankruptcy protection in 2019 as it faced thousands of lawsuits over the opioid crisis. Among the claims are that ...

Purdue Pharma, 603 U.S. 204 (2024), where a ... third-party nondebtors without the consent of affected claim holders. The bankruptcy bar and courts are now attempting to determine the breadth ...

Mallinckrodt Pharmaceuticals and Endo have agreed to combine in a nearly $7bn deal after the pair emerged from bankruptcy processes linked to liabilities over the US opioid crisis.

Purdue Pharma planned to exit bankruptcy last year under terms that gave the Sacklers a full release from all civil opioid claims even though they themselves were not declaring bankruptcy.

Supreme Court hears case that could shield Purdue Pharma owners from opioid lawsuits The Supreme Court heard arguments in one of the most important corporate bankruptcy cases in decades.

A New York bankruptcy judge’s recognition of a Mexican lender’s foreign restructuring with nonconsensual liability releases ...